Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Cells|January 11, 2022
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 TherapyTonino Alonzi, Alessandra Aiello, Linda Petrone, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 24, 2022
Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseasesLinda Petrone, Andrea Picchianti-Diamanti, Gian Domenico Sebastiani, et al.
Infectious Disease Reports|February 25, 2025
Impact of Severity of COVID-19 in TB Disease Patients: Experience from an Italian Infectious Disease Referral HospitalVirginia Di Bari, Carlotta Cerva, Raffaella Libertone, et al.
Frontiers in Immunology|May 13, 2021
PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active DiseaseGermana Grassi, Valentina Vanini, Federica De Santis, et al.
Vaccines|May 7, 2025
Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive TherapiesMario Ferraioli, Alessandra Aiello, Immacolata Prevete, et al.
Frontiers in Neurology|June 17, 2022
Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple SclerosisLinda Petrone, Carla Tortorella, Alessandra Aiello, et al.
Frontiers in Immunology|January 28, 2025
Specific immune response to <i>M. tuberculosis</i> and ability to <i>in vitro</i> control mycobacterial replication are not impaired in subjects with immune-mediated inflammatory disease and tuberculosis infectionChiara Farroni, Anna Maria Gerarda Altera, Andrea Salmi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 25, 2022
Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4<sup>+</sup> and CD8<sup>+</sup> T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assayAlessandra Aiello, Andrea Coppola, Valentina Vanini, et al.
Vaccines|August 29, 2024
Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 VaccinationAlessandra Aiello, Serena Ruggieri, Assunta Navarra, et al.
Scientific Reports|April 24, 2022
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccineChiara Agrati, Concetta Castilletti, Delia Goletti, et al.
Pageof 6